From: UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
GO-term | Description | False discovery rate |
---|---|---|
Biological process (BP) | ||
GO:0016925 | Protein sumoylation | 8.43e−24 |
GO:0033235 | Positive regulation of protein sumoylation | 5.45e−06 |
GO:0032436 | Positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 9.15e−06 |
GO:0043085 | Positive regulation of catalytic activity | 8.30e−04 |
GO:0065009 | Regulation of molecular function | 1.20e−03 |
Molecular function (MF) | ||
GO:0019789 | SUMO transferase activity | 9.18e−14 |
GO:0044388 | Small protein activating enzyme binding | 2.99e−10 |
GO:0019899 | Enzyme binding | 9.43e−08 |
GO:0031386 | Protein tag | 3.48e−07 |
GO:0008022 | Protein C-terminus binding | 6.65e−07 |
Cellular component (CC) | ||
GO:0016605 | PML body | 3.45e−12 |
GO:0031510 | SUMO activating enzyme complex | 1.34e−07 |
GO:0044428 | Nuclear part | 1.73e−06 |
GO:0005654 | Nucleoplasm | 5.48e−06 |
GO:0044614 | Nuclear pore cytoplasmic filaments | 5.48e−05 |